PT Kimia Farma Tbk (ISX:KAEF) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:KAEF PT Kimia Farma Tbk ISX:KAEF
58 GF Score
Price Rp454.00
GF Value Rp581.28
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Kimia Farma Tbk FFO?

FFO (Funds from operations) only applies to REITs.

ISX:KAEF
58GF Score
PT Kimia Farma Tbk ISX:KAEF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PT Kimia Farma Tbk (ISX:KAEF) Overvalued in 2026?

Based on GuruFocus' analysis, PT Kimia Farma Tbk stock appears to be undervalued. The current stock price of Rp454.00 is trading 21.9% below its estimated GF Value™ of Rp581.28. GuruFocus considers PT Kimia Farma Tbk to be Modestly Undervalued.

Key valuation signals for ISX:KAEF:

  • FFO:
  • GF Value™: Rp581.28 vs. price of Rp454.00 (21.9% below fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Kimia Farma Tbk Business Description

Address Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
58GF Score

Get the complete analysis for ISX:KAEF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp454.00
Price
Rp581.28
GF Value